The AAAS honored Dr. Feldman for her distinguished contributions to neuroscience and neurology, particularly through leadership, mentoring, and basic and clinical research, leading to new disease therapies and important clinical guidelines.
Dr. Eva Feldman shares a message for the annual World Diabetes Day. She talks about two new diabetes centers at Michigan Medicine and the ongoing fight against COVID-19's deadly affect on those afflicted with the disease.
Dr. Eva Feldman gave a "Wheelhouse Talk" at Grand Valley State University's Hauenstein Presidential Studies Center, where she shared life lessons from her own personal and professional experiences as a Michigan Medicine clinician scientist.
The 2020 Wolfe Neuropathy Research Prize honors an outstanding investigator who identifies a new cause or treatment of neuropathy. Dr. Brian Callaghan was recognized for his work with obesity and neuropathy.
In a study led by Dr. Rodica Pop-Busui, NeuroNetwork for Emerging Therapies faculty member, preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications.
In addition to his diabetes research, Dr. Callaghan seeks to improve the efficiency in neurologic testing. Here he examined how a change to Medicare's nerve conduction study reimbursement policy in 2013 has affected the utilization, payments and patient access to the the procedure, which measures the speed at which an electrical impulse moves
While Catrina Robinson, PhD , is the most recent addition to the NeuroNetwork for Emerging Therapies roster of scientists, she has a long-standing relationship with Director Eva L. Feldman, M.D., Ph.D.